Primary Immunodeficiencies in a Mesoregion of São Paulo, Brazil: Epidemiologic, Clinical, and Geospatial Approach
Open Access
- 12 May 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 862
Abstract
Background: Primary immunodeficiencies (PIDs) are rare genetic disorders leading to immunologic abnormalities that can affect different organs and systems. We determined the epidemiology, clinical, and geospatial characteristics of PID disorders among patients diagnosed over a 5-year period in a reference hospital covering a mesoregion in São Paulo, Brazil. Methods: A retrospective analysis of 39 patients with recognizable PIDs according to the criteria of the European Society of Primary Immunodeficiencies were enrolled. Thirty-four patients came from outpatient immunodeficiency clinics and 5 patients from active search. Demographic, clinical, and immunologic data were collected, and maps were constructed using a geographic information system. Results: The ratio of females to males was 1.4:1, and 48.7% of patients were younger than 17 years of age. The mean age at the onset of symptoms in children was 2.0 years (standard error of the mean [SEM], 1.7 years) and the diagnosis lag was 5.1 years (SEM, 3.1 years); the mean age at diagnosis in adults was 16.3 years (SEM, 11.8 years) and the lag was 10.8 years (SEM, 10.9 years). Antibody deficiency and common variable immunodeficiencies were the most common categories and phenotypes, respectively. The need for intravenous antibiotics and respiratory tract infections were the most prevalent warning signs, with an overall mortality rate of 15.3%. Autoimmune diseases were diagnosed in 56.4% and visceral leishmaniasis in 5.1% of patients. In the active search, 29 patients were investigated and 17.2% were diagnosed; early diagnosis, the involvement of multidisciplinary professionals, and dissemination of knowledge achieved milestone benefits. The distribution of PID networks in Brazil shows great asymmetry between regions and at a regional level; it was shown that the patients lived mainly in Presidente Prudente municipality. Conclusions: The implementation of an immunodeficiency outpatient clinic in a referral hospital covering a mesoregion with a large population has led to the generation of policies and practices to improve the diagnosis, quality of life, and care of patients with PIDs and their families. Furthermore, the search for hospitalized patients with warning signs for PIDs showed great benefits. Inequality in the distribution of PID network centers in Brazil was demonstrated.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo
This publication has 22 references indexed in Scilit:
- The German National Registry of Primary Immunodeficiencies (2012–2017)Frontiers in Immunology, 2019
- Unusual manifestations of visceral leishmaniasis in children: a case series and its spatial dispersion in the western region of São Paulo state, BrazilBMC Infectious Diseases, 2019
- Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular DiagnosisJournal of Clinical Immunology, 2018
- The broad spectrum of lung diseases in primary antibody deficienciesEuropean Respiratory Review, 2018
- Saúde da criança no Brasil: orientação da rede básica à Atenção Primária à SaúdeCiencia & Saude Coletiva, 2016
- Clinical Features, Non-Infectious Manifestations and Survival Analysis of 161 Children with Primary Immunodeficiency in Mexico: A Single Center Experience Over two DecadesJournal of Clinical Immunology, 2015
- Diagnosing primary immunodeficiency: a practical approach for the non-immunologistCurrent Medical Research and Opinion, 2015
- Primary Immunodeficiency Diseases in Egyptian Children: A Single-Center StudyJournal of Clinical Immunology, 2008
- Population Prevalence of Diagnosed Primary Immunodeficiency Diseases in the United StatesJournal of Clinical Immunology, 2007
- Primary Immunodeficiency Diseases in Latin America: The Second Report of the LAGID RegistryJournal of Clinical Immunology, 2006